Patalinghug, Shella Mae J.
HRN: 18-78-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2022
CEFUROXIME 750MG (VIAL)
10/04/2022
10/10/2022
IV
375
Q8
Wound Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes